FDA Inspection 1222946 — Community Blood Center Of Greater Kansas City
The FDA completed an inspection of Community Blood Center Of Greater Kansas City on Nov 14, 2023 in Overland Park, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 14, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Overland Park, KS (United States)